Page 57 - TD-1-1

Tumor Discovery Dual-targeting of cancer receptors by nanoparticles

There are no duplicate publication, fraud, plagiarism, or magnetic nanoparticle for mitoxantrone delivery toward
concerns about animal or human experimentation. CD44-positive cancer cells. Colloids Surfaces B Biointerfaces,
171: 150–158.
References 14. Dosio F, Arpicco S, Stella B, et al., 2016, Hyaluronic acid for

1. Jordan VC, 2006, Tamoxifen (ICI46, 474) as a targeted anticancer drug and nucleic acid delivery. Adv Drug Deliv
therapy to treat and prevent breast cancer. Br J Pharmacol, Rev, 97: 204–236.
147: S269–S276. 15. Sargazi A, Kamali N, Shiri F, et al., 2018, Hyaluronic acid/
2. Dehghani F, Farhadian N, Golmohammadzadeh S, et al., polyethylene glycol nanoparticles for controlled delivery of
2017, Preparation, characterization and in-vivo evaluation mitoxantrone. Artif Cells Nanomed Biotechnol, 46: 500–509.
of microemulsions containing tamoxifen citrate anti-cancer 16. Soleymani M, Velashjerdi M, Shaterabadi Z, et al., 2020,
drug. Eur J Pharm Sci, 96: 479–489. One-pot preparation of hyaluronic acid‐coated iron oxide
3. Majd MH, Akbarzadeh A, Sargazi A, 2017, Evaluation of nanoparticles for magnetic hyperthermia therapy and
host-guest system to enhance the tamoxifen efficiency. Artif targeting CD44-overexpressing cancer cells. Carbohydr
Cells Nanomed Biotechnol, 45: 441–447. Polym, 237: 116130.
4. Kempe S, Mäder K, 2012, In situ forming implants an 17. Li L, Gao F, Jiang W, et al., 2016, Folic acid-conjugated
attractive formulation principle for parenteral depot superparamagnetic iron oxide nanoparticles for tumor-
formulations. J Control Release, 161: 668–679. targeting MR imaging. Drug Deliv, 23: 1726–1733.
5. Khdair A, Hamad I, Alkhatib H, et al., 2016, Modified- 18. Sargazi A, Azhoogh M, Allahdad S, et al., 2018, Evaluation
chitosan nanoparticles: Novel drug delivery systems of supramolecule conjugated magnetic nanoparticles as
improve oral bioavailability of doxorubicin. Eur J Pharm Sci, a simultaneous carrier for methotrexate and tamoxifen. J
93: 38–44. Drug Deliv Sci Technol, 47: 115–122.
6. Jerban S, Chang EY, Du J, 2020, Magnetic resonance imaging 19. Akbarian A, Ebtekar M, Pakravan N, et al., 2020, Folate
(MRI) studies of knee joint under mechanical loading. Magn receptor alpha targeted delivery of artemether to breast
Reson Imaging, 65: 27–36. cancer cells with folate-decorated human serum albumin
nanoparticles. Int J Biol Macromol, 152: 90–101.
7. Jose J, Kumar R, Harilal S, et al., 2020, Magnetic nanoparticles
for hyperthermia in cancer treatment: An emerging tool. 20. Sargazi A, Aliabadi A, Rahdari A, et al., 2017, A simple
Environ Sci Pollut Res, 27: 19214–19225. and fast method for magnetic solid phase extraction of
ochratoxin a. J Braz Chem Soc, 28: 950–959.
8. Sadeghi M, Jahanshahi M, Javadian H, 2019, Synthesis and
characterization of a novel Fe O -SiO @Gold core-shell 21. Sajja HK, East MP, Mao H, et al., 2009, Development of
2
3
4
biocompatible magnetic nanoparticles for biological and multifunctional nanoparticles for targeted drug delivery and
medical applications. J Nanomed Res J, 4: 193–203. noninvasive imaging of therapeutic effect. Curr Drug Discov
Technol, 6: 43–51.
9. Ali S, Khan SA, Eastoe J, et al., 2018, Synthesis,
characterization, and relaxometry studies of hydrophilic and 22. Shahraki S, Majd MH, Heydari A, 2019, Novel tetradentate
hydrophobic superparamagnetic Fe O nanoparticles for oil Schiff base zinc(II) complex as a potential antioxidant
3
4
reservoir applications. Colloids Surfaces A Physicochem Eng and cancer chemotherapeutic agent: Insights from the
Aspects, 543: 133–143. photophysical and computational approach. J Mol Struct,
1177: 536–544.
10. Gao F, Wu X, Wu D, et al., 2020, Preparation of degradable
magnetic temperature-and redox-responsive polymeric/ 23. Mansouri-Torshizi H, Zareian-Jahromi S, Ghahghaei A, et
Fe O nanocomposite nanogels in inverse miniemulsions al., 2018, Palladium(II) complexes of biorelevant ligands.
4
3
for loading and release of 5-fluorouracil. Colloids Surfaces A Synthesis, structures, cytotoxicity and rich DNA/HSA
Physicochem Eng Aspects, 587: 124363. interaction studies. J Biomol Struct Dyn, 36: 2787–2806.
11. Fotukian SM, Barati A, Soleymani M, et al., 2020, 24. Shahraki S, Shiri F, Heidari Majd M, et al., 2019, Anti-cancer
Solvothermal synthesis of CuFe O and Fe O nanoparticles study and whey protein complexation of new lanthanum(III)
4
4
2
3
with high heating efficiency for magnetic hyperthermia complex with the aim of achieving bioactive anticancer
application. J Alloys Compd, 816: 152548. metal-based drugs. J Biomol Struct Dyn, 37: 2072–2085.
12. Azizi S, Nosrati H, Danafar H, 2020, Simple surface 25. Barar J, Kafil V, Majd MH, et al., 2015, Erratum to:
functionalization of magnetic nanoparticles with Multifunctional mitoxantrone-conjugated magnetic
methotrexate-conjugated bovine serum albumin as a nanosystem for targeted therapy of folate receptor-
biocompatible drug delivery vehicle. Appl Organomet Chem, overexpressing malignant cells. J Nanobiotechnol, 13: 26.
34: e5479.
26. Sargazi A, Barani A, Majd MH, 2020, Synthesis and
13. Sargazi A, Shiri F, Keikha S, et al., 2018, Hyaluronan apoptotic efficacy of biosynthesized silver nanoparticles
Volume 1 Issue 1 (2022) 8 https://doi.org/10.36922/td.v1i1.41